Clinical trials
Completed Metabolic Diseases trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 2 |
| 2013 | 3 |
| 2017 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 8 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 4 |
| Chinese Medical Association | 3 |
| Beijing Sport University | 1 |
| First Affiliated Hospital of Chongqing Medical University | 1 |
| Fudan University | 1 |
| Huashan Hospital | 1 |
| Nanfang Hospital, Southern Medical University | 1 |
| Nanjing Medical University | 1 |
| Shaoguan University | 1 |
| Shenzhen Center for Chronic Disease Control | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Diseases | 20 |
| Insulin Resistance | 6 |
| Diabetes Mellitus | 5 |
| Diabetes Mellitus, Type 2 | 5 |
| Endocrine System Diseases | 4 |
| Critical Illness | 3 |
| Glucose Metabolism Disorders | 3 |
| Immune System Diseases | 3 |
| Autoimmune Diseases | 2 |
| Cardiovascular Diseases | 2 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.